Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood glucose level changes with propofol and midazolam in type 2 diabetes patients undergoing cataract surgery
IRCT201501126115N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propofol and midazolam in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Perioperative blood glucose level change. Started Aug 2013; status: completed.
02
Drugs
propofolmidazolam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201501126115N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201501126115N2.